Memorial Sloan Kettering Cancer Center(MSK) shared a post on LinkedIn:
“In honor of International Clinical Trials Day, Memorial Sloan Kettering Cancer Center (MSK) celebrates its clinical research staff, trial participants, and administrators for their invaluable contributions in advancing innovative cancer treatment therapies and cures.
With over 1,100 clinical research experts, MSK provides patients with exceptional access to innovative treatments through an extensive range of clinical trials. MSK clinicians, clinical care providers, and clinical research administrators work together to drive groundbreaking discoveries, bringing new and expanding treatment options to cancer patients here and around the world.
‘Successful clinical trials are the only way forward to improve outcomes for patients,’ says Dr. Paul Sabbatini, Senior Vice President of Clinical Research at MSK. ‘The impact of the MSK clinical research enterprise also extends far beyond our institution, changing standards of care for patients around the world. By driving discoveries that influence oncology practice globally, MSK remains at the forefront of delivering transformative advances that offer hope to patients and families everywhere.’ “
Other articles about Memorial Sloan Kettering Cancer Center.